Biomaterial Database

[Antipsychotic drugs with long lasting effect. Depot neuroleptics]. 1980

P Kristjansen

UI	MeSH Term	Description	Entries
D003692	Delayed-Action Preparations	Dosage forms of a drug that act over a period of time by controlled-release processes or technology.	Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014150	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.	Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major

Related Publications

P Kristjansen

The long-acting depot antipsychotic drugs.

October 2003, Hospital medicine (London, England : 1998),

P Kristjansen

[Long acting neuroleptics--depot-neuroleptics].

May 1974, Tijdschrift voor ziekenverpleging,

P Kristjansen

Antiparkinson drugs and depot neuroleptics.

August 1982, The British journal of psychiatry : the journal of mental science,

P Kristjansen

Depot antipsychotic drugs revisited.

October 1998, Psychiatric services (Washington, D.C.),

P Kristjansen

[Remission with long-lasting antipsychotic agent].

June 2007, Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology,

P Kristjansen

[Neuroprotective effect of antipsychotic drugs (neuroleptics) in global brain ischemia].

January 2006, Eksperimental'naia i klinicheskaia farmakologiia,

P Kristjansen

Depot antipsychotic drugs. Place in therapy.

May 1994, Drugs,

P Kristjansen

[Combination of two depot antipsychotic drugs].

July 2014, Der Nervenarzt,

P Kristjansen

[Experience with long-acting depot--neuroleptics in schizophrenic psychoses].

May 1973, Activitas nervosa superior,